TAM2 serves as an important driving factor in immunosuppressive TME and, for instance, the secreted TGF-β induces regulatory T cells (Treg) and inhibits CD8+ T-cell responses to kill the cancer cells.4 The population of TAM1 or TAM2 can be used as a prognostic factor in cancer therapy.5 This evidence concerns the gene CD8A and cancer.